# Kiora Pharmaceuticals Announces Management Team Changes
Canonical URL: https://biopharmsignal.com/news/KPRX/kiora-pharmaceuticals-announces-management-team-changes
Ticker: KPRX
Company: Kiora Pharmaceuticals
Source: Kiora Pharmaceuticals
Published: 2026-04-02 20:30 EST
Original Source URL: https://ir.kiorapharma.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-02 11:00 EST — [Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium](https://biopharmsignal.com/news/KPRX/kiora-pharmaceuticals-to-participate-in-piper-sandler-virtual-ophthalmology-symp-a9cd7ac0) — Source: Kiora Pharmaceuticals
- 2026-06-18 11:00 EST — [Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model](https://biopharmsignal.com/news/KPRX/kiora-pharmaceuticals-reports-its-ion-channel-modulator-kio-300-suppressed-seizu-6aa93b6c) — Source: Kiora Pharmaceuticals
- 2026-05-08 11:00 EST — [Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/KPRX/kiora-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: Kiora Pharmaceuticals
- 2026-04-14 11:00 EST — [Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway](https://biopharmsignal.com/news/KPRX/kiora-s-phase-1-abacus-study-of-kio-301-in-retinitis-pigmentosa-published-in-nature-medicine-phase-2-trial-underway) — Source: Kiora Pharmaceuticals
- 2026-04-07 11:00 EST — [Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors](https://biopharmsignal.com/news/KPRX/kiora-pharmaceuticals-announces-private-placement-for-up-to-24-million-led-by-perceptive-advisors) — Source: Kiora Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)